The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial,The BMJ

当前位置： X-MOL 学术 › BMJ › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial
The BMJ ( IF 93.6 ) Pub Date : 2025-05-30 , DOI: 10.1136/bmj.r1098
British Medical Journal Publishing Group

Some of the data in this paper by Wu and colleagues ( BMJ 2025;388:e082583, doi:10.1136/bmj-2024-082583, published 15 January 2025) have been updated. Disruptions to clinical service during the covid-19 pandemic affected the data verification process at some of the trial centres leading to inaccurate data being entered …

中文翻译：

胸腺肽 α1 治疗脓毒症的疗效和安全性（TESTS）：多中心、双盲、随机、安慰剂对照、3 期试验

Wu 及其同事在这篇论文中的一些数据（BMJ 2025;388：e082583， doi：10.1136/bmj-2024-082583，发布于 2025 年 1 月 15 日）已更新。covid-19 大流行期间临床服务中断影响了一些试验中心的数据验证过程，导致输入的数据不准确......

更新日期：2025-05-30

点击分享查看原文

点击收藏

阅读更多本刊新发论文